Patents by Inventor David Park Meininger

David Park Meininger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified lecithin-cholesterol acyltransferase enzymes
    Patent number: 9006408
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: April 14, 2015
    Assignee: Amgen Inc.
    Inventors: Mingyue Zhou, Wenyan Shen, Bei Shan, Margrit Schwarz, David Park Meininger, Tom Boone
  • MODIFIED LECITHIN-CHOLESTEROL ACYLTRANSFERASE ENZYMES
    Publication number: 20140287479
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 25, 2014
    Applicant: Amgen Inc.
    Inventors: Mingyue Zhou, Wenyan Shen, Bei Shan, Margrit Schwarz, David Park Meininger, Tom Boone
  • Modified lecithin-cholesterol acyltransferase enzymes
    Patent number: 8703926
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: April 22, 2014
    Assignee: Amgen Inc.
    Inventors: Mingyue Zhou, Wenyan Shen, Bei Shan, Margrit Schwarz, David Park Meininger, Tom Boone
  • Modified lecithin-cholesterol acyltransferase enzymes
    Patent number: 8168416
    Abstract: The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: May 1, 2012
    Assignee: Amgen Inc.
    Inventors: Tom Boone, David Park Meininger, Margrit Schwarz, Bei Shan, Wenyan Shen, Mingyue Zhou